Acute Withdrawal Considerations | June 25, 2024
Date of Presentation: June 25, 2024
Type: Past Presentation
Audience: Clinical
Program: Grand Rounds
Keywords: #alcohol #benzodiazepine #buprenorphine #cocaine #management #methadone #methamphetamine #opioid #polysubstance #substances #SUD #symptoms #withdrawal
In this presentation, Dr. Kathryn Hawk, MD, MHS & Dr. Ryan Buckley, MD, MPH, review management of common withdrawal syndromes (alcohol use, opioid use, benzodiazepine use, methamphetamine and cocaine use), as well as provide management options for complex withdrawal syndromes (severe alcohol withdrawal syndrome, precipitated withdrawal syndrome, polysubstance use and commitment withdrawal) ithrough case-based discussion. The one-hour Grand Rounds session includes an opportunity to engage in a didactic presentation, gain insight on how Indian Health Service, Tribal and Urban Indian (I/T/U) facilities may effectively manage common withdrawal symptoms, become part of a learning community, join a SUD ECHO program and ask clinical questions.
Recording:
Presented by:
Ryan JJ Buckley (Cherokee Nation)
MD, MPH
Ryan Buckley, MD, is an Instructor of Emergency Medicine at Yale
Kathryn Hawk
MD, MHS
Kathryn Hawk, MD, MHS is an attending physician in the Yale New Haven Hospital Emergency Department and an Associate Professor in the Department of Emergency Medicine, the Yale School of Public Health and the Program in Addiction Medicine. She was a National Institute on Drug Abuse (NIDA) K12 sponsored Drug use, Addiction and HIV Research (DAHRS) Scholar, and is board certified in emergency and addiction medicine. She completed her residency training and research fellowship in the Yale University Department of Emergency Medicine. Her research primarily focuses on the design, testing and implementation of evidence based-care for ED patients with substance use disorders, with a focus on initiating medications for the treatment of opioid and alcohol use disorder in the ED and maximizing effective linkage to ongoing treatment using innovative strategies. Her research on quality improvement and reducing opioid-associated mortality through data linkages, overdose prevention and harm reduction strategies, implementation-facilitation ED-initiated buprenorphine for opioid use disorder, initiating treatment for alcohol use disorder in the ED and the dissemination of evidence-based best practices for care of patients with addiction has been funded by NIDA, the NIDA Clinical Trials Network, Centers for Disease Control and Prevention (CDC), Emergency Medicine Foundation (EMF), Foundation for Opioid Response (FORE), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA).
Brigg Reilley
Faculty
Brigg Reilley has worked with IHS and NPAIHB for a combined 12 years, starting with the HIV program. Brigg now supports the National Program’s management and evaluation for HIV and HCV. Prior to IHS, he worked for Doctors without Borders in several international projects and for the Office of Public Health in Louisiana. Brigg has an MPH from Tulane University.
Read the full bio …Resources Provided:
Date added: May 23, 2024